Day: December 16, 2021

Acuity Brands to Announce Fiscal 2022 First Quarter Results on January 7, 2022

Acuity Brands to Announce Fiscal 2022 First Quarter Results on January 7, 2022

Atlanta, GA, Dec. 16, 2021 (GLOBE NEWSWIRE) — Acuity Brands, Inc. (NYSE: AYI) (“Company”) today announced that the Company is planning to release its fiscal 2021 first-quarter earnings results on Friday, January 7th, at 6:00 a.m. (EDT) to be followed by a conference call at 8:00 a.m. (EDT).  Neil Ashe, Chairman, President and Chief Executive Officer of Acuity Brands, will lead the call.   The conference call and earnings release can be accessed via the Investor Relations section of the Company’s website at investors.acuitybrands.com. The online replay will remain available for a limited time following the call. A replay of the call will also be posted to the Investor Relations site within two hours of the completion of the conference call and will be archived on the site.   To learn more about Acuity Brands, please visit...

Continue reading

Quanex Building Products Announces Fourth Quarter and Fiscal Year 2021 Results

Quanex Building Products Announces Fourth Quarter and Fiscal Year 2021 Results

Record Revenue Growth & Earnings in FY21 Balance Sheet & Liquidity Continue to Improve and Remain Strong Board Authorizes New $75 Million Share Repurchase Program HOUSTON, Dec. 16, 2021 (GLOBE NEWSWIRE) —  Quanex Building Products Corporation (NYSE:NX) (“Quanex” or the “Company”) today announced its results for the three months and twelve months ended October 31, 2021. The Company also announced that its Board of Directors (the “Board) has authorized a new $75 million share repurchase program to return capital to shareholders. The Company reported the following selected financial results: QUANEX BUILDING PRODUCTS CORPORATION                   Q4 2021 Earnings Release                           Three Months Ended October 31,   Twelve Months Ended October 31,   ($ in millions, except per share data)     2021       2020       2021       2020     Net...

Continue reading

Ekso Bionics Announces EksoNR Multi-Unit Order by Nebraska Fraternal Order of Eagles

Ekso Bionics Announces EksoNR Multi-Unit Order by Nebraska Fraternal Order of Eagles

– Foundation Donates Units to Two Inpatient Rehabilitation Facilities in Nebraska – RICHMOND, Calif., Dec. 16, 2021 (GLOBE NEWSWIRE) — Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that the Nebraska Chapter of the Fraternal Order of Eagles (“F.O.E.”), an international nonprofit community organization, has purchased two EksoNR devices on behalf of local Nebraska inpatient rehabilitation facilities. The EksoNR devices will be donated to the Inpatient Rehabilitation Unit at Bryan Medical Center, a 30-bed unit in Lincoln, Neb., and Nebraska Methodist Hospital & Rehabilitation Center’s 22-bed rehabilitation facility in Omaha, Neb. More than 60% of the typical patient population at both facilities stand to benefit...

Continue reading

Petra Acquisition, Inc. Announces Special Meeting of Stockholders to Approve Business Combination with Revelation Biosciences, Inc.

Petra Acquisition, Inc. Announces Special Meeting of Stockholders to Approve Business Combination with Revelation Biosciences, Inc.

-The Definitive Proxy Statement Has Been Filed with The Securities and Exchange Commission- -Stockholders Special Meeting Scheduled for January 6, 2022- NEW YORK and SAN DIEGO, Dec. 16, 2021 (GLOBE NEWSWIRE) — Petra Acquisition, Inc. (NASDAQ: PAICU, PAIC, & PAICW), (“Petra”) a special purpose acquisition company, today announced that it will hold a Special Meeting of Stockholders (the “Special Meeting”) to vote on the approval of the proposed Business Combination (the “Business Combination”) with Revelation Biosciences, Inc. (“Revelation”), a clinical-stage life sciences company that is focused on the development of immunologic‑based therapies for the prevention and treatment of disease. The Special Meeting is scheduled to be held on January 6, 2022, at 10:00 a.m., Eastern Time, virtually via live webcast. Petra common stockholders...

Continue reading

<div>UPDATE - The Oncology Institute of Hope & Innovation Celebrates 50th Practice Location</div>

UPDATE – The Oncology Institute of Hope & Innovation Celebrates 50th Practice Location

New Hillcrest clinic offers cutting-edge oncology treatment in San Diego neighborhood SAN DIEGO, Dec. 16, 2021 (GLOBE NEWSWIRE) — The Oncology Institute of Hope & Innovation (NASDAQ: TOI), one of the largest value-based community oncology groups in the United States, recently commemorated the opening of their 50th nationwide clinic with a ribbon-cutting ceremony and celebration at the newest location in Hillcrest neighborhood of San Diego, California. Chief Operations Officer Daniel Virnich, MD, MBA, welcomed guests with remarks detailing TOI’s mission of offering comprehensive, personalized cancer care in the local community. TOI physician and Medical Director Dr. Phillip Saunders also spoke about how TOI is uniquely positioned to provide patient-centric care. “We are honored to open our 50th location in Hillcrest and bring...

Continue reading

<div>UPDATE - The Oncology Institute of Hope & Innovation Adds Los Angeles Practices to Network</div>

UPDATE – The Oncology Institute of Hope & Innovation Adds Los Angeles Practices to Network

TOI is excited to welcome additional physicians to its team of 80+ employed clinicians LOS ANGELES, Dec. 16, 2021 (GLOBE NEWSWIRE) — The Oncology Institute for Hope and Innovation (TOI), one of the largest value-based community oncology groups in the United States, recently acquired the practices of Ellsworth R. Grant, MD, and Leo E. Orr, MD, expanding TOI’s network of more than 80 specially trained physicians and advanced practice providers. “By joining with TOI, I can continue to provide personalized care to my patients while leveraging TOI’s outstanding medical resources,” Dr. Grant stated. Dr. Orr agreed, adding, “I am proud to join such a well-respected group of practitioners with a powerful reputation for cutting-edge care.” The new Westlake facility will provide patients with the same advanced medical services and health...

Continue reading

Power Solutions International Announces Additional $50 Million Shareholder Loan Agreement With Weichai America

Power Solutions International Announces Additional $50 Million Shareholder Loan Agreement With Weichai America

WOOD DALE, Ill., Dec. 16, 2021 (GLOBE NEWSWIRE) — Power Solutions International, Inc. (the “Company” or “PSI”) (OTC Pink: PSIX), a leader in the design, engineering and manufacture of emission-certified engines and power systems, announced today that it entered into an additional shareholder’s loan agreement with its majority stockholder, Weichai America Corp. (“Weichai”), dated as of December 10, 2021 (the “Third Shareholder’s Loan Agreement”). The Third Shareholder’s Loan Agreement, which matures on November 30, 2022, provides the Company with access to up to $50 million of credit at the discretion of Weichai to supplement the Company’s working capital. The Third Shareholder’s Loan Agreement is subordinated in all respects to the Company’s existing $130 million senior secured revolving credit facility with Standard Chartered...

Continue reading

UPDATE - The Oncology Institute Completes Business Combination with DFP Healthcare Acquisitions Corp. to Become Publicly-Traded Company

UPDATE – The Oncology Institute Completes Business Combination with DFP Healthcare Acquisitions Corp. to Become Publicly-Traded Company

NEW YORK and LOS ANGELES, Dec. 16, 2021 (GLOBE NEWSWIRE) — The Oncology Institute (“TOI” or “The Company”), the U.S. market leader in value-based oncology care, announced today that it has closed its previously announced business combination with DFP Healthcare Acquisitions Corp. (“DFPH”). The transaction was approved at a special meeting of DFP’s stockholders on November 12, 2021. The combined company was renamed “The Oncology Institute” and will be led by its existing management team. Its shares of common stock and warrants began trading today on NASDAQ under the new ticker symbols “TOI” and “TOIIW”. The transaction implies an enterprise value for TOI of $842 million. In connection with the transaction, TOI raised approximately $334 million of cash proceeds, which includes $275 million from a previously announced private placement...

Continue reading

Abeona Therapeutics Announces Public Offering of Common Stock and Warrants

Abeona Therapeutics Announces Public Offering of Common Stock and Warrants

NEW YORK and CLEVELAND, Dec. 16, 2021 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced that it intends to offer and sell shares of its common stock and warrants to purchase common stock in an underwritten public offering pursuant to an existing shelf registration statement. All of the securities in the offering are to be sold by Abeona. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Cantor Fitzgerald & Co. is acting as sole book-running manager for the offering, and A.G.P./Alliance Global Partners is acting as lead manager for the offering. Abeona intends to use the net proceeds of the offering to fund continued clinical...

Continue reading

Middlesex Water Removes PFOA Impacted Wells from Service

Middlesex Water Removes PFOA Impacted Wells from Service

ISELIN, N.J., Dec. 16, 2021 (GLOBE NEWSWIRE) — Middlesex Water Company today announced that it has implemented an interim plan that can produce additional water from its primary surface water treatment plant and other sources to enable the Company to turn off the wells which tested above state limits for the new PFOA standard. The wells have been shut down and the Company is currently replacing that water supply with alternate sources that comply with all state and federal drinking water standards. “In conjunction with extensive monitoring, testing and hydraulic modeling, we have turned off the wells and are continuing to keep the wells off as we work with the New Jersey Department of Environmental Protection to implement and comply with the change in source water regulatory requirements associated with the interim plan,” said...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.